ZKZiemowit Klimonda

Ziemowit Klimonda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ziemowit Klimonda has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Assessment of neoadjuvant chemotherapy in breast tumors based on local tumor tissue response to therapy

    by Ziemowit Klimonda, Piotr Karwat, Katarzyna Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Jerzy Litniewski

  • Open Access

    Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy Using Probability Maps Derived from Quantitative Ultrasound Parametric Images

    by Piotr Karwat, Hanna Piotrzkowska-Wróblewska, Ziemowit Klimonda, Katarzyna S. Dobruch-Sobczak, Jerzy Litniewski

    Objective: Neoadjuvant chemotherapy (NAC) is widely used in the treatment of breast cancer. However, to date, there are no fully reliable, non-invasive methods for monitoring NAC. In this article, we propose a new method for classifying NAC-responsive and unresponsive tumors using quantitative ultrasound. Methods: The study used ultrasound data collected from breast tumors treated with NAC. The proposed method is based on the hypothesis that areas that characterize the effect of therapy particularly well can be found. For this purpose, parametric images of texture features calculated from tumor images were converted into NAC response probability maps, and areas with a probability above 0.5 were used for classification. Results: The results obtained after the third cycle of NAC show that the classification of tumors using the traditional method (area under the ROC curve AUC = 0.81 - 0.88) can be significantly improved thanks to the proposed new approach (AUC = 0.84–0.94). This improvement is achieved over a wide range of cutoff values (0.2-0.7), and the probability maps obtained from different quantitative parameters correlate well. Conclusion: The results suggest that there are tumor areas that are particularly well suited to assessing response to NAC. Significance: The proposed approach to monitoring the effects of NAC not only leads to a better classification of responses, but also may contribute to a better understanding of the microstructure of neoplastic tumors observed in an ultrasound examination.


  • Preliminary assessment of the effectiveness of neoadjuvant chemotherapy in breast cancer with the use of ultrasound image quality indexes

    by Anna Pawłowska, Norbert Żołek, Beata Leśniak-Plewińska, Katarzyna Dobruch-Sobczak, Ziemowit Klimonda, Hanna Piotrzkowska-Wróblewska, Jerzy Litniewski


  • Deep meta-learning for the selection of accurate ultrasound based breast mass classifier

    by Michal Byra, Piotr Karwat, Ivan Ryzhankow, Piotr Komorowski, Ziemowit Klimonda, Lukasz Fura, Anna Pawlowska, Norbert Zolek, Jerzy Litniewski

    Standard classification methods based on hand-crafted morphological and texture features have achieved good performance in breast mass differentiation in ultrasound (US). In comparison to deep neural networks, commonly perceived as ‘black-box’ models, classical techniques are based on features that have well-understood medical and physical interpretation. However, classifiers based on morphological features commonly underperform in the presence of the shadowing artifact and ill-defined mass borders, while texture based classifiers may fail when the US image is too noisy. Therefore, in practice it would be beneficial to select the classification method based on the appearance of the particular US image. In this work, we develop a deep meta-network that can automatically process input breast mass US images and recommend whether to apply the shape or texture based classifier for the breast mass differentiation. Our preliminary results demonstrate that meta-learning techniques can be used to improve the performance of the standard classifiers based on handcrafted features. With the proposed meta-learning based approach, we achieved the area under the receiver operating characteristic curve of 0.95 and accuracy of 0.91.


  • Open Access

    Estimating the ultrasound attenuation coefficient using convolutional neural networks -- a feasibility study

    by Piotr Jarosik, Michal Byra, Marcin Lewandowski, Ziemowit Klimonda

    Attenuation coefficient (AC) is a fundamental measure of tissue acoustical properties, which can be used in medical diagnostics. In this work, we investigate the feasibility of using convolutional neural networks (CNNs) to directly estimate AC from radio-frequency (RF) ultrasound signals. To develop the CNNs we used RF signals collected from tissue mimicking numerical phantoms for the AC values in a range from 0.1 to 1.5 dB/(MHz*cm). The models were trained based on 1-D patches of RF data. We obtained mean absolute AC estimation errors of 0.08, 0.12, 0.20, 0.25 for the patch lengths: 10 mm, 5 mm, 2 mm and 1 mm, respectively. We explain the performance of the model by visualizing the frequency content associated with convolutional filters. Our study presents that the AC can be calculated using deep learning, and the weights of the CNNs can have physical interpretation.

  • Joint segmentation and classification of breast masses based on ultrasound radio-frequency data and convolutional neural networks

    by Michal Byra, Piotr Jarosik, Katarzyna Dobruch-Sobczak, Ziemowit Klimonda, Hanna Piotrzkowska-Wroblewska, Jerzy Litniewski, Andrzej Nowicki


  • Assessment of breast cancer response to neoadjuvant chemotherapy based on ultrasound backscattering envelope statistics

    by Ziemowit Klimonda, Piotr Karwat, Katarzyna Dobruch‐Sobczak, Hanna Piotrzkowska‐Wróblewska, Jerzy Litniewski

    Purpose: Neo‐adjuvant chemotherapy (NAC) is used in breast cancer before tumor surgery to reduce the size of the tumor and the risk of spreading. Monitoring the effects of NAC is important because in a number of cases the response to therapy is poor and requires a change in treatment. A new method that uses quantitative ultrasound to assess tumor response to NAC has been presented. The aim was to detect NAC unresponsive tumors at an early stage of treatment.Methods: The method assumes that ultrasound scattering is different for responsive and nonresponsive tumors. The assessment of the NAC effects was based on the differences between the histograms of the ultrasound echo amplitude recorded from the tumor after each NAC dose and from the tissue phantom, estimated using the Kolmogorov–Smirnov statistics (KSS) and the symmetrical Kullback–Leibler divergence (KLD). After therapy, tumors were resected and histopathologically evaluated. The percentage of residual malignant cells was determined and was the basis for assessing the tumor response. The data set included ultrasound data obtained from 37 tumors. The performance of the methods was assessed by means of the area under the receiver operating characteristic curve (AUC).Results: For responding tumors, a decrease in the mean KLD and KSS values was observed after subsequent doses of NAC. In nonresponding tumors, the KLD was higher and did not change in subsequent NAC courses. Classification based on the KSS or KLD parameters allowed to detect tumors not responding to NAC after the first dose of the drug, with AUC equal 0.830.06 and 0.840.07, respectively. After the third dose, the AUC increased to 0.900.05 and 0.910.04, respectively.Conclusions: The results indicate the potential usefulness of the proposed parameters in assessing the effectiveness of the NAC and early detection of nonresponding cases.


  • Open Access

    Quantitative Assessment of the Echogenicity of a Breast Tumor Predicts the Response to Neoadjuvant Chemotherapy

    by Katarzyna Sylwia Dobruch-Sobczak, Hanna Piotrzkowska-Wróblewska, Piotr Karwat, Ziemowit Klimonda, Ewa Markiewicz-Grodzicka, Jerzy Litniewski

    The aim of the study was to improve monitoring the treatment response in breast cancer patients undergoing neoadjuvant chemotherapy (NAC). The IRB approved this prospective study. Ultrasound examinations were performed prior to treatment and 7 days after four consecutive NAC cycles. Residual malignant cell (RMC) measurement at surgery was the standard of reference. Alteration in B-mode ultrasound (tumor echogenicity and volume) and the Kullback-Leibler divergence (kld), as a quantitative measure of amplitude difference, were used. Correlations of these parameters with RMC were assessed and Receiver Operating Characteristic curve (ROC) analysis was performed. Thirty-nine patients (mean age 57 y.) with 50 tumors were included. There was a significant correlation between RMC and changes in quantitative parameters (KLD) after the second, third and fourth course of NAC, and alteration in echogenicity after the third and fourth course. Multivariate analysis of the echogenicity and KLD after the third NAC course revealed a sensitivity of 91%, specificity of 92%, PPV = 77%, NPV = 97%, accuracy = 91%, and AUC of 0.92 for non-responding tumors (RMC ≥ 70%). In conclusion, monitoring the echogenicity and KLD parameters made it possible to accurately predict the treatment response from the second course of NAC.


  • Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer Sonography Using Siamese Convolutional Neural Networks

    by Michal Byra, Katarzyna Dobruch-Sobczak, Ziemowit Klimonda, Hanna Piotrzkowska-Wroblewska, Jerzy Litniewski

    Early prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer is crucial for guiding therapy decisions. In this work, we propose a deep learning based approach for the early NAC response prediction in ultrasound (US) imaging. We used transfer learning with deep convolutional neural networks (CNNs) to develop the response prediction models. The usefulness of two transfer learning techniques was examined. First, a CNN pre-trained on the ImageNet dataset was utilized. Second, we applied double transfer learning, the CNN pre-trained on the ImageNet dataset was additionally fine-tuned with breast mass US images to differentiate malignant and benign lesions. Two prediction tasks were investigated. First, a L1 regularized logistic regression prediction model was developed based on generic neural features extracted from US images collected before the chemotherapy (a priori prediction). Second, Siamese CNNs were used to quantify differences between US images collected before the treatment and after the first and second course of NAC. The proposed methods were evaluated using US data collected from 39 tumors. The better performing deep learning models achieved areas under the receiver operating characteristic curve of 0.797 and 0.847 in the case of the a priori prediction and the Siamese model, respectively. The proposed approach was compared with a method based on handcrafted morphological features. Our study presents the feasibility of using transfer learning with CNNs for the NAC response prediction in US imaging.